Compounds and methods for targeted immune system delivery are disclosed. Pharmaceutical compositions including the disclosed compounds and a pharmaceutically acceptable excipient are also disclosed. Methods of targeted delivery to an antigen- presenting cell, and methods of treating or preventing a disease or condition susceptible to treatment by immunomodulation are disclosed
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Compounds and methods for targeted immune system delivery are disclosed. Pharmaceutical compositions...
The present invention pertains to therapeutic compositions that comprise: (1) a nanovector, (2) an a...
The present invention provides compositions and methods for targeting cells for therapeutic and/or d...
The present invention provides compositions and methods for targeting cells for therapeutic and/or d...
Compounds and compositions comprising these compounds, which have immunomodulatory activity and/or a...
Pharmaceuticals for human use comprise a very wide variety of product types. These include tradition...
Pharmaceuticals for human use comprise a very wide variety of product types. These include tradition...
Pharmaceuticals for human use comprise a very wide variety of product types. These include tradition...
Immunomodulation in infectious diseases, cancer, cardiovascular disease and autoimmunity can now be ...
Compounds and compositions comprising these compounds, which have immunomodulatory activity and/or a...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Compounds and methods for targeted immune system delivery are disclosed. Pharmaceutical compositions...
The present invention pertains to therapeutic compositions that comprise: (1) a nanovector, (2) an a...
The present invention provides compositions and methods for targeting cells for therapeutic and/or d...
The present invention provides compositions and methods for targeting cells for therapeutic and/or d...
Compounds and compositions comprising these compounds, which have immunomodulatory activity and/or a...
Pharmaceuticals for human use comprise a very wide variety of product types. These include tradition...
Pharmaceuticals for human use comprise a very wide variety of product types. These include tradition...
Pharmaceuticals for human use comprise a very wide variety of product types. These include tradition...
Immunomodulation in infectious diseases, cancer, cardiovascular disease and autoimmunity can now be ...
Compounds and compositions comprising these compounds, which have immunomodulatory activity and/or a...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...